la
pneumoni
peh
est
courant
pendant
lenfanc
le
viru
sont
respons
de
la
plupart
de
ca
de
peh
au
cour
de
deux
de
vie
cett
de
comm
le
streptococcu
pneumonia
le
mycoplasma
pneumonia
et
le
chlamydia
pneumonia
devienn
plu
le
de
peh
ne
sont
pa
chez
le
nourrisson
mai
une
toux
et
une
se
manifest
chez
le
enfant
plu
une
radiographi
pulmonair
est
util
pour
confirm
le
diagnost
il
est
possibl
de
prendr
en
charg
la
plupart
de
enfant
de
empiriqu
au
moyen
dantibiotiqu
oraux
prescrit
en
cliniqu
extern
san
explor
en
laboratoir
le
enfant
atteint
dune
infect
grave
ou
dont
le
persist
ou
saggrav
ont
besoin
de
subir
de
explor
plu
intens
et
il
se
peut
quil
doivent
le
choix
et
la
posologi
de
lantibiotiqu
doivent
de
du
patient
de
la
de
la
pneumoni
et
de
la
connaiss
de
locaux
de
antimicrobienn
la
canadienn
de
recommand
lusag
du
vaccin
antipneumococciqu
heptaval
qui
est
efficac
pour
jusqu
de
pneumoni
par
radiographi
c
ommunityacquir
pneumonia
cap
lower
respiratori
tract
infect
occur
child
resid
hospit
health
care
facil
preced
day
recent
studi
incid
first
episod
pneumonia
unimmun
children
younger
five
year
age
per
personyear
estim
canadian
children
younger
five
year
age
nonhospit
cap
anoth
hospit
annual
etiolog
pneumonia
often
easi
ascertain
clinic
set
greatest
clue
age
child
vertic
transmiss
organ
matern
genit
tract
main
rout
entri
pathogen
neonat
earli
infanc
period
primari
organ
respons
pneumonia
first
three
month
life
group
b
streptococci
gramneg
bacilli
occat
listeria
monocytogen
three
week
three
month
life
infant
may
present
insidu
afebril
pneumon
syndrom
caus
chlamydia
trachomati
overal
virus
common
caus
pneumonia
first
two
year
life
account
pneumonia
commonli
implic
virus
respiratori
syncyti
viru
parainfluenza
viru
type
influenza
viru
type
b
adenoviru
rhinovirus
less
commonli
herp
simplex
viru
enterovirus
increas
age
incid
pneumonia
decreas
bacteri
pathogen
includ
streptococcu
pneumonia
mycoplasma
pneumonia
chlamydia
pneumonia
becom
frequent
children
year
age
pneumonia
account
communityacquir
pneumonia
case
introduct
pneumococc
proteinconjug
vaccin
unit
state
canadian
provinc
led
substanti
reduct
pneumonia
caus
invas
diseas
region
includ
pneumonia
overal
rate
invas
pneumococc
infect
decreas
proport
isol
penicillin
ceftriaxon
resist
increas
develop
lead
chang
empir
antibiot
choic
children
present
pneumonia
region
among
schoolag
children
virus
account
onehalf
pneumonia
case
pneumonia
second
common
agent
pneumonia
becom
common
pathogen
young
adolesc
identifi
onehalf
case
c
pneumonia
second
common
agent
pneumonia
among
young
adolesc
account
onethird
pneumonia
case
symptom
pneumonia
neonat
nonspecif
includ
poor
feed
hypotonia
floppi
lethargi
apnea
temperatur
elev
depress
hypotens
older
children
presenc
respiratori
infect
may
character
tachypnea
occasion
hypoxia
progress
apnea
need
ventilatori
support
world
health
organ
defin
clinic
criteria
make
diagnosi
pneumonia
criteria
consist
presenc
cough
associ
tachypnea
tachypnea
defin
respiratori
rate
breathsmin
children
one
five
year
old
breathsmin
children
two
month
old
breathsmin
children
two
month
old
use
world
health
organ
guidelin
associ
sensit
specif
correctli
identifi
pneumonia
confirm
chest
xray
chest
xray
may
discret
airspac
airway
involv
diffus
reticulonodular
pattern
indistinguish
pictur
seen
hyalin
membran
diseas
patient
c
trachomati
pneumonia
usual
present
afebril
pneumonia
associ
staccato
cough
tachypnea
progress
difficulti
breath
chest
xray
find
bilater
pulmonari
infiltr
air
trap
conjunct
half
case
chest
examin
may
reveal
diffus
crackl
wheez
usual
featur
laboratori
examin
may
includ
elev
total
immunoglobulin
eosinophilia
bacteri
pneumonia
classic
associ
abrupt
onset
chill
rigor
product
sound
cough
truli
product
cough
uncommon
children
child
commonli
appear
toxic
physic
examin
reveal
decreas
breath
sound
crackl
typic
confin
one
lobe
chest
xray
usual
confirm
lobar
involv
contrast
atyp
pneumonia
insidi
onset
associ
nonproduct
cough
lowgrad
fever
gener
children
toxic
bacteri
pneumonia
chest
xray
show
diffus
involv
note
typic
bacteri
pathogen
pneumonia
haemophilu
influenza
commonli
associ
classic
present
atyp
pneumonia
commonli
associ
pneumonia
c
pneumonia
howev
organ
may
present
either
fashion
somewher
two
extrem
clinic
pictur
legionella
pneumophila
pneumonia
rare
children
unless
immunocompromis
child
particularli
adolesc
present
cough
fever
consider
given
tuberculosi
proper
histori
alway
includ
whether
child
live
tuberculosi
endem
area
contact
person
high
risk
first
nation
peopl
immigr
endem
area
urban
homeless
incarcer
individu
person
human
immunodefici
viru
infect
clue
tuberculosi
includ
subacut
present
anorexia
weight
loss
night
sweat
product
sputum
hemoptysi
differenti
c
pneumonia
pneumonia
infect
tuberculosi
pertussi
consid
differenti
diagnosi
children
present
symptom
sign
cap
particularli
cough
catarrh
promin
howev
pertussi
rare
caus
radiolog
confirm
pneumonia
sever
acut
respiratori
syndrom
sar
associ
coronaviru
recent
ad
list
pathogen
caus
pneumonia
diseas
character
temperatur
one
clinic
find
respiratori
ill
eg
cough
short
breath
difficulti
breath
hypoxia
sever
case
radiograph
evid
pneumonia
respiratori
distress
syndrom
autopsi
find
consist
pneumonia
respiratori
distress
syndrom
without
identifi
caus
addit
need
travel
endem
area
within
day
symptom
onset
close
contact
person
known
suspect
sar
unclear
whether
condit
remain
major
problem
come
year
import
clue
etiolog
pneumonia
includ
exposur
parrot
psittacin
bird
chlamydia
psittaci
infect
exposur
farm
anim
sheep
goat
cattl
cat
coxiella
burnetti
travel
southwestern
unit
state
northern
mexico
part
central
south
america
coccidioid
immiti
travel
resid
eastern
central
unit
state
canada
histoplasma
capsulatum
suspicion
diagnosi
clinic
ground
follow
chest
xray
confirm
due
lack
agreement
clinic
pneumonia
radiologicallyconfirm
pneumonia
prevent
unnecessari
antibiot
use
like
diagnosi
viral
bronchiti
followup
chest
xray
indic
except
child
present
recurr
pneumonia
followup
film
use
determin
whether
resolut
episod
latter
scenario
children
mildli
moder
ill
respiratori
distress
abl
eat
drink
alert
cooper
manag
expectantli
without
specif
test
empir
treatment
usual
effect
children
persist
worsen
symptom
underli
ill
sever
diseas
need
intens
investig
manag
prioriti
investig
communityacquir
pneumonia
children
confirm
common
caus
quickli
diagnos
caus
would
respond
treatment
empir
antibiot
bacteria
identifi
nasal
throat
cultur
predict
valu
identifi
organ
caus
pneumonia
test
current
use
rapid
viral
diagnos
elev
white
cell
count
left
shift
increas
likelihood
bacteri
infect
predict
enough
distinguish
viral
bacteri
pneumonia
creactiv
protein
also
like
elev
patient
bacteri
viral
pneumonia
much
overlap
test
clinic
use
assay
base
polymeras
chain
reaction
use
recent
studi
diagnos
pneumonia
c
pneumonia
c
trachomati
yet
routin
avail
practic
physician
febril
children
blood
specimen
obtain
bacteri
cultur
cultur
yield
organ
case
decis
child
need
hospit
admiss
made
casebycas
basi
use
factor
hydrat
statu
oxygen
statu
toxic
appear
lack
respons
oral
therapi
recurr
underli
diseas
patient
inadequ
oral
intak
diarrhea
intraven
hydrat
antibiot
given
children
hypox
respiratori
distress
receiv
oxygen
may
need
posit
endexpiratori
airway
pressur
ventil
choic
antibiot
suspect
bacteri
pneumonia
base
age
group
child
empir
treatment
neonat
reflect
recommend
treatment
neonat
sepsi
children
three
week
three
month
age
afebril
pneumonia
syndrom
infanc
macrolid
erythromycin
given
infant
sever
pneumonia
admit
intens
care
unit
also
receiv
coverag
staphylococcu
aureu
h
influenza
tabl
children
age
three
month
five
year
pneumonia
frequent
bacteri
organ
penicillin
firstand
secondgener
cephalosporin
remain
effect
even
children
pneumonia
due
penicillinresist
pneumonia
reason
ampicillin
drug
choic
expert
recommend
increas
dose
ensur
adequ
serum
lung
level
macrolid
also
ad
empir
treatment
age
group
cover
pneumonia
c
pneumonia
particularli
outpati
random
clinic
trial
compar
erythromycin
either
clarithromycin
azithromycin
shown
newer
agent
equal
effect
mani
fewer
side
effect
tabl
summar
canadian
consensu
guidelin
empir
manag
pneumonia
children
modif
ampicilin
recommend
take
consider
possibl
penicillinresist
pneumonia
estim
case
nonhospit
hospit
cap
case
respect
canadian
children
less
five
year
age
due
pneumonia
heptaval
pneumococc
vaccin
prevnar
wyethayest
canada
licens
canada
sinc
june
unit
state
sinc
februari
four
dose
vaccin
given
infant
two
month
four
month
six
month
month
age
case
pneumonia
reduc
episod
pneumonia
associ
posit
davi
bartlett
et
al
area
signific
rate
intermedi
high
level
penicillin
resist
streptococcu
pneumonia
daili
dosag
mgkg
mgkg
recommend
younger
infant
month
year
higher
dose
recommend
chest
xray
reduc
among
confirm
case
intent
treat
analysi
vaccin
work
best
children
younger
one
year
age
reduct
pneumonia
associ
abnorm
chest
xray
compar
infant
first
two
year
two
year
age
base
data
impact
invas
pneumococc
diseas
canadian
paediatr
societi
nation
advisori
committe
immun
recommend
routin
immun
canadian
children
age
two
month
two
year
older
children
highrisk
group
eg
patient
sickl
cell
anemia
asplen
patient
human
immunodefici
viru
infect
immunocompromis
certain
chronic
diseas
pneumococc
heptaval
vaccin
